![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 51, 49366-49373, December 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cellular and Molecular Physiology,
Yale University School of Medicine, New Haven, Connecticut
06520-8026
Received for publication, August 23, 2002, and in revised form, October 8, 2002
Intracellular ATP and membrane-associated
phosphatidylinositol phospholipids, like PIP2
(PI(4,5)P2), regulate the activity of ATP-sensitive
K+ (KATP) and Kir1.1 channels by direct
interaction with the pore-forming subunits of these channels. We
previously demonstrated direct binding of TNP-ATP
(2',3'-O-(2,4,6-trinitrophenylcyclo-hexadienylidene)-ATP) to the
COOH-terminal cytosolic domains of the pore-forming subunits of Kir1.1
and Kir6.x channels. In addition, PIP2 competed for TNP-ATP
binding on the COOH termini of Kir1.1 and Kir6.x channels, providing a
mechanism that can account for PIP2 antagonism of ATP
inhibition of these channels. To localize the ATP-binding site within
the COOH terminus of Kir1.1, we produced and purified maltose-binding
protein (MBP) fusion proteins containing truncated and/or mutated
Kir1.1 COOH termini and examined the binding of TNP-ATP and competition
by PIP2. A truncated COOH-terminal fusion protein
construct, MBP_1.1C ATP-sensitive K+ (KATP) channels couple
cell metabolism to K+ channel activity (3-7).
KATP channels are formed by four pore-forming subunits
(Kir6.x) in association with four subunits of sulfonylurea receptors
(8), SUR1 or SUR2a/b. Kir1.1 has many properties similar to
these KATP channels and has been suggested to interact with
the cystic fibrosis transmembrane conductance regulator or SUR2b to
form a glibenclamide-sensitive and ATP-inhibited channel (9, 10).
Nucleotides can both inhibit and activate KATP channels (3,
4, 11). Inhibition of KATP channel activity is mediated by
binding of ATP to the Kir subunits, whereas channel activation by ADP
occurs upon interaction with the SUR subunits. Phosphatidylinositol phosphates (e.g. phosphatidylinositol 4,5 diphosphate,
PIP2)1 compete
with ATP for gating of KATP channels (12-16). The effect of PIP2 to antagonize the inhibitory action of ATP provides
a mechanism for opening KATP channels in intact cells in
the presence of cytosolic ATP concentrations that would otherwise be
inhibitory (13, 16-18).
We recently localized the ATP-binding region to the COOH terminus
in each of the three ATP-regulated channels: Kir1.1, Kir6.1, and Kir6.2
(19). We found that maltose-binding (MBP) fusion proteins containing
Kir1.1 or Kir6.x COOH termini are efficiently produced in bacteria, are
soluble without detergent, and directly bind TNP-ATP with a
stoichiometry of at least one ATP per COOH-terminal monomer. In
addition, we showed that phosphatidylinositol phospholipids competed
for ATP binding to the COOH termini of Kir6.x and Kir1.1 channels (2),
providing a mechanism for PIP2 antagonism of ATP effects.
Kir1.1 or ROMK, originally cloned from rat kidney outer medulla
(20), forms the small conductance ATP-regulated K+ channel
involved in apical K+ recycling in thick ascending limb and
in K+ secretion in principal cells of the mammalian kidney
(11). Mutations in the human ROMK gene (Kcnj1) that cause
loss of channel function give rise to Bartter's syndrome, which is
characterized by volume depletion resulting from renal salt wasting
(21, 22). Mice with deletion of the ROMK (Kir1.1) gene exhibit a
phenotype consistent with Bartter's syndrome with polyuria, increased
urinary Na+ loss, and extracellular fluid volume depletion
(23). The ROMK-deficient mice have no small conductance channel
activity on apical membranes of thick ascending limb or principal
cells, consistent with ROMK encoding the small conductance
K+ recycling/secretory channel in kidney.
In the present study, we further localized the ATP binding within the
COOH terminus of Kir1.1. We assessed TNP-ATP binding and its antagonism
by PIP2 to purified maltose-binding fusion proteins with
deletions of the cytosolic COOH terminus of Kir1.1. The
ATP-PIP2 binding domain was localized to the first 39 amino acids of the COOH terminus of Kir1.1. We also defined specific arginine
residues within this 39-amino acid domain that are critical for TNP-ATP
binding. Because these arginine residues are conserved in the Kir6.x
channels, similar domains in these channels are likely to also form
ATP-binding pockets.
DNA Constructs and Mutagenesis--
Complementary DNA encoding
the COOH terminus of Kir1.1 (amino acids 183-391) was derived from rat
Kir1.1a (ROMK1; Ref. 20). The Kir1.1 COOH terminus was subcloned into a
XbaI and PstI-digested pMBPT vector (19, 24). The
deletions and single amino acid substitutions in the COOH terminus of
Kir1.1 were generated using PCR. All full-length and truncated
C-terminal fragments of Kir1.1 included a stop codon and were ligated
in-frame with MBP. All DNA constructs were verified by PCR and cycle
sequencing (Keck Facility, Yale) and then transformed into Epicurian
coli® BL21-CodonPlusTM-RIL competent cells (Stratagene, La Jolla, CA)
for the protein expression.
Production and Purification of Maltose-binding Fusion
Proteins--
Recombinant proteins were expressed as previously
described by us (19). Briefly, 1 liter of Luria-Bertani medium with 0.1 mg/ml ampicillin and 0.2% glucose was inoculated with 10 ml of an
overnight culture of BL21 cells expressing the fusion vector and grown
to an A600 of ~0.5 at 37 °C. Induction was
performed with 0.3 mM isopropyl
TNP-ATP Binding--
Binding of ATP to these recombinant
fusion proteins was performed generally as described previously (19).
Briefly, 5 µM recombinant protein was dissolved in 50 mM Tris-HCl at pH 7.5, and TNP-ATP binding was detected by
the increase in fluorescence (Ex = 403 nm; 546 nm; slit widths 5 nm) upon binding to recombinant protein using a Fluromax-3
spectrofluorometer (Jobin Yvon Inc., Edison, NJ). Temperature was
maintained at 22 ± 0.1 °C by a circulating water bath (Neslab,
Portsmouth, NH). Incremental additions of TNP-ATP were delivered
to plastic cuvettes from stock solutions (0.2-1.0 mM).
Protein was denatured by addition of 4 M urea where indicated.
The TNP-ATP fluorescence enhancement factor (
As shown in Equation 4, using individual Localization of the TNP-ATP Binding Segment in the Kir1.1 COOH
Terminus--
The concentration-dependence relationships of TNP-ATP
fluorescence (Fobs) with full-length
(MBP_1.1C-WT) and deletion mutants of the Kir1.1 COOH terminus are
shown in Fig. 1A. The numbers associated with the construct names in Fig. 1A indicate the
length of the deletion from the carboxyl end of the COOH-terminal
construct. Fobs increased in a non-linear,
concentration-dependent manner with all COOH-terminal
deletions from 84 to 180 amino acid residues. TNP-ATP fluorescence
increased above that seen for MBP_1.1C-WT with deletion of 84 residues
(MBP_1.1C
Fluorescence enhancement (
TNP-ATP binding affinities (Kd values) and
stoichiometries (N) were calculated from Equation 1 for the
three constructs that gave 10 µM
Fobs values greater than WT (Fig. 1B)
and are summarized in Fig. 2. The Kd
(µM) for TNP-ATP binding was significantly increased in
MBP_1.1C
We also assessed the effects of truncations of the
NH2-terminal end of the COOH terminus of Kir1.1 on the
concentration dependence of TNP-ATP fluorescence (Fig.
3). These deletions were from the initial
region of the COOH terminus just distal to the second membrane-spanning
segment. Recombinant MBP proteins with deletions from 10-124 amino
acid residues (MBP_1.1C
We further examined TNP-ATP fluorescence increases with truncation of
the NH2-terminal end of the MBP_1.1
To verify that the TNP-ATP binding domain is contained
within the initial 39 amino acid residues of the COOH terminus of
Kir1.1 (MBP_1.1C The Kinetics of TNP-ATP Binding to the Truncated COOH Terminus of
Kir1.1--
The Mutation of Single Residues in the First 39 Amino Acids
of the COOH Terminus Abolish TNP-ATP Binding--
Mutation of a number
of residues in the COOH terminus of Kir6.2 have been shown to reduce
sensitivity of this KATP channel to ATP and/or
PIP2 (14, 27-29). Because channel gating is a complex process involving at a minimum both the binding of ATP and the subsequent closing of the channel pore, we examined the effects of some
of these mutations on TNP-ATP binding to MBP_1.1C PIP2 Competition of TNP-ATP Binding to the Truncated
COOH Terminus of Kir1.1 MBP Fusion Proteins--
Our recent
observations (2) indicated that PIP2 directly bound to the
COOH termini of Kir1.1 and that PIP2 competed with TNP-ATP
for the binding to MBP_1.1C. Here we further evaluated the ability of
PIP2 to compete for TNP-ATP binding to the COOH-terminal 39-amino acid binding segment of Kir1.1. Fig.
7A (left panel) shows the typical TNP-ATP fluorescence increases associated with binding of this nucleotide to MBP_1.1 Our previous study provided direct evidence that TNP-ATP can bind
to the COOH termini of Kir1.1 and the ATP-sensitive K+
channels, Kir6.1 and Kir6.2 (19). Because TNP-ATP did not bind to the
NH2 termini of Kir1.1 or Kir6.1, the COOH terminus of
ATP-regulated K+ channels was both necessary and sufficient
to bind nucleotides. The present observations support the suggestion
that ATP inhibition of KATP channel activity is mediated by
interaction of ATP with the COOH terminus of the Kir subunit. Here we
have further localized the nucleotide binding segment of Kir1.1 to the
initial 39 amino acid residues of the COOH terminus. In addition, we
show that specific residues within this segment are critical to
nucleotide binding. Finally, we demonstrate that this 39-residue
segment also retains the critical sequences necessary for
PIP2 competition of TNP-ATP binding.
Several lines of evidence indicate that the initial 39 amino acid
residues of the COOH terminus of Kir1.1 is the minimal segment necessary for the high affinity binding of TNP-ATP and for
PIP2 competition and that this segment is the only
significant adenine nucleotide-binding region along the COOH terminus
of Kir1.1. First, MBP_1.1C All three arginine residues that affect TNP-ATP binding in Kir1.1
(Arg188, Arg203, and
Arg217) are conserved in Kir6.x channels (Fig.
5) as well as most Kir channels, the only exception being that
Arg203 is a histidine residue in Kir4.1. Mutation of any of
these three residues in Kir6.2 (Arg177,
Arg192, or Arg206; Fig.
5) has been shown to alter channel gating by ATP and/or PIP2 (14). Because ATP and PIP2 are competitive
regulators of KATP channel gating and we have shown that
TNP-ATP and PIP2 interactions occur within the same
39-amino acid segment (Fig. 7), this mutational study in Kir6.2 is
fully consistent with our observations of the critical roles of
Arg188 and Arg217 in nucleotide binding (Fig.
6). Interestingly, the R201A mutation in Kir6.2 (Fig. 5A),
corresponding to R212A in Kir1.1, reduces Kir6.2 channel gating by ATP
and PIP2, whereas this mutation in Kir1.1 has no effect on
TNP-ATP binding (Fig. 6C) and enhances competition of
TNP-ATP binding by PIP2 (Fig. 7B). This suggests that Arg201 in Kir6.2 functions differently than
Arg212 in Kir1.1 for ATP binding or that Arg201
in Kir6.2 affects channel gating by a mechanism other than modification of direct binding of ATP. Finally, a number of other residues in the
first 39 amino acids of Kir6.2 have also been shown to affect ATP
and/or PIP2 gating of channel activity (14, 27-29) or the
binding of 8-azido-[ We previously suggested that TNP-ATP binds to the COOH termini of
Kir1.1 and the Kir6.x ATP-sensitive channels with a stoichiometry of at
least one molecule of ATP binding per COOH-terminal protein (19). The
TNP-ATP/protein stoichiometry of 0.78 for the entire Kir1.1 COOH
terminus (MBP_1.1C-WT) confirms our previous observations of a single
adenine nucleotide binding site for each of the four Kir subunits
forming the kidney ATP-regulated K+ channel. The present
results provide additional support for this model by demonstrating that
TNP-ATP binding is confined to a single short segment in the COOH
terminus of Kir1.1. Although the No for MBP_1.1C One of the major regulatory mechanisms of Kir1.1 and KATP
channels, as well as other Kir K+ channels, is channel
gating (opening) by phosphatidylinositol phospholipids like
PIP2. PIP2 competition of the inhibitory action of ATP provides a mechanism for opening KATP channels in
intact cells in the presence of millimolar concentrations of cytosolic ATP. We have recently reported that PIP2 competed with
TNP-ATP binding to the COOH terminus of Kir1.1 and Kir6.x channels. Our present results show that the 39-amino acid nucleotide binding domain
in the COOH termini of Kir1.1 retains the ability of PIP2 to compete off TNP-ATP. Thus, the initial 39-amino acid residue segment
in the COOH terminus of Kir1.1 represents both the ATP binding domain
and a PIP2 binding segment. The enhancement, rather than
diminution, of PIP2 competition of TNP-ATP binding in the R212A mutant suggests that the effect of mutation of the similar residue in Kir6.2 (14) on PIP2-ATP interactions may involve a mechanism other than ATP-PIP2 competition for binding. It
should be noted, however, that although the initial COOH-terminal
sequences of Kir1.1 and Kir6.2 are similar, they are not identical.
Thus, it is possible that certain distinct amino acid residues in
Kir6.2 may change the role of this arginine residue in PIP2
binding compared with Kir1.1.
In summary, we have defined a 39-amino acid segment in the Kir1.1
(ROMK) COOH terminus that forms an ATP-PIP2 binding domain and have identified three arginine residues that significantly alter
TNP-ATP binding. Because this region is similar and the three critical
arginine residues are conserved in Kir6.x channels (Fig.
5B), it seems likely that the initial COOH-terminal segment in KATP channels also forms an ATP-PIP2 binding domain.
*
This work was supported by Grant DK54999 from the National
Institutes of Health (to S. C. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Cellular and
Molecular Physiology, Yale University School of Medicine, 333 Cedar
St., SHM B147, P.O. Box 208026, New Haven, CT 06520-8026. Tel.:
203-785-6696; Fax: 203-785-7678; E-mail: steven.hebert@yale.edu.
Published, JBC Papers in Press, October 14, 2002, DOI 10.1074/jbc.M208679200
The abbreviations used are:
PIP2, phosphatidylinositol 4,5 diphosphate;
MBP, maltose binding protein;
a.u., arbitrary unit;
WT, wild type;
TNP, 2',3'-O-(2,4,6-trinitrophenylcyclo-hexadienylidene);
ROMK, renal outer
medulla potassium channel.
Localization of the ATP/Phosphatidylinositol 4,5 Diphosphate-binding Site to a 39-Amino Acid Region of the Carboxyl
Terminus of the ATP-regulated K+ Channel Kir1.1*
,
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
C170, containing the first 39 amino acid residues
distal to the second transmembrane domain was sufficient to bind
TNP-ATP with high affinity. A construct containing the remaining
COOH-terminal segment distal to the first 39 amino acid residues did
not bind TNP-ATP. Deletion of 5 or more amino acid residues from the
NH2-terminal side of the COOH terminus abolished nucleotide
binding to the entire COOH terminus or to the first 49 amino acid
residues of the COOH terminus. PIP2 competed TNP-ATP binding to MBP_1.1C
C170 with an EC50 of 10.9 µM. Mutation of any one of three arginine residues
(R188A/E, R203A, and R217A), which are conserved in Kir1.1 and
KATP channels and are involved in ATP and/or
PIP2 effects on channel activity, dramatically reduced TNP-ATP binding to MBP_1.1
C170. In contrast, mutation of a
fourth conserved residue (R212A) exhibited slightly enhanced TNP-ATP binding and increased affinity for PIP2 competition of
TNP-ATP (EC50 = 5.7 µM). These studies
suggest that the first 39 COOH-terminal amino acid residues form an
ATP-PIP2 binding domain in Kir1.1 and possibly the Kir6.x
ATP-sensitive K+ channels.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactoside at 37 °C for 2 h. The cells
were harvested and centrifuged at 4,000 × g for
20 m at 4 °C. The cell pellet was resuspended in 50 ml of
Column Buffer (in mM: 20 Tris-HCl, 200 NaCl, 1 EDTA, pH
7.4) and frozen overnight at
20 °C. The sample was thawed in ice
water and lysed with a probe sonicator (4 times for 30 s, with
30-s intervals) in an ice-water bath. The sample was then centrifuged
at 9,000 × g for 30 min at 4 °C. The supernatant
was kept and diluted 1:5 with Column Buffer. The diluted extract was
loaded into a 25-ml column containing 15 ml of amylose resin and washed
with 12 column volumes of Column Buffer. The fusion protein was eluted
with Column Buffer plus 10 mM maltose, and 1.5-ml fractions
were collected. Protein was detected by UV absorbance at 280 nm,
dialyzed against 50 mM Tris-HCl, pH 7.5, and kept at
80 °C until experiments. All MBP fusion proteins were efficiently
expressed, except for MBP_1.1C
180, and could be purified at
milligram quantities (10-25 mg/liter of bacterial culture) without
exposure to detergents or denaturing agents. All MBP fusion proteins
ran as single bands at their expected molecular masses on 10% PAGE gels.
) with binding to
proteins, TNP-ATP to protein subunit stoichiometry (N), and dissociation constant (Kd, µM) were
determined using a modified version of the binding equation derived by
Faller (25) and as modified by us (19) using GraphPad PRISMTM 3.0 software. As seen in Equation I, observed fluorescence intensity
(Fobs) in arbitrary units (a.u.) is given by
where P is the protein concentration (µM). Q and
Q2 are constants (fluorescence intensity per
µM or µM2 of free TNP-ATP,
respectively) derived independently from the concentration dependence
of TNP-ATP fluorescence intensity in buffer alone
(FBuffer) and account for the inner filter
effect (25): Fbuffer =
Q[TNP-ATP] + Q2[TNP-ATP]2.
Qc is the slope of the FBuffer
versus (TNP-ATP) curve in buffer alone as shown in Equation 2.
(Eq. 1)
Protein light scatter intensity (Flight
scatter) was subtracted from all Fobs values.
(Eq. 2)
was measured at a fixed TNP-ATP concentration of 5 µM
by determining the increase in Fobs with
increasing protein concentration. The Fobs data
were fit well by a single exponential and
F
(Eq. 3)
values we
calculated the concentrations of free (F) and bound
(B) TNP-ATP as described by Moczydlowski and Fortes
(26).
(F) is then the difference between total (TNP-ATP)
and (B). Bound versus free TNP-ATP plots were
analyzed using a standard binding model that follows mass action as
seen in Equation 5,
(Eq. 4)
where Bmax is the maximal TNP-ATP
binding. Data were also plotted for Scatchard analysis as described
(19).
(Eq. 5)
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
C84). In contrast, further truncations of the distal COOH
terminus up to 136 residues (MBP_1.1C
C136) reduced maximal
fluorescence with 10 µM TNP-ATP below that of MBP_1.1C
C84 and to the fluorescence of MBP_1.1C-WT (Fig. 1,
A and B). However, with truncations of 160 (MBP_1.1C
C160) or 170 (MBP_1.1C
C170) residues, 10 µM TNP-ATP fluorescence significantly increased to levels
greater than that for MBP_1.1C-WT (Fig. 1). However, truncation of 180 residues (MBP_1.1C
C180) dramatically reduced TNP-ATP fluorescence to
below that for MBP_1.1C-WT. Because protein production was greatly
reduced for MBP_1.1C
C180, further study of this construct was not
performed. Finally, denaturing each of the MBP fusion proteins with 4 M urea significantly reduced the
concentration-dependent TNP-ATP fluorescence increases
(data not shown), consistent with TNP-ATP binding as described
previously by us (19).

View larger version (29K):
[in a new window]
Fig. 1.
The effects of truncations of the
distal COOH terminus of Kir1.1 on concentration-dependent
increases in TNP-ATP fluorescence
(Fobs). MBP fusion protein constructs
with truncations of 84 (MBP_1.1C
C84), 102 (MBP_1.1C
C102), 119 (MBP_1.1C
C119), 136 (MBP_1.1C
C136), 160 (MBP_1.1C
C160), 170 (MBP_1.1C
C170), and 180 (MBP_1.1C
C180) amino acid residues in the COOH
terminus of Kir1.1 were produced in bacteria, purified, and
5-µM concentrations were exposed to varying
concentrations of TNP-ATP. A, TNP-ATP fluorescence
enhancement was monitored with increasing TNP-ATP concentrations. The
dashed line represents TNP-ATP increases with full-length
COOH terminus (MBP_1.1C-WT) for comparison. TNP-ATP
fluorescence increased in a non-linear manner and was well fit by
Equation 1 for each construct (solid lines), consistent with
TNP-ATP binding. Binding fluorescence increases were greatest for
MBP_1.1C
C170. The small Fobs with TNP-ATP in
50 mM Tris buffer indicates unbound fluorescence
(clear diamonds). B, comparison of maximal 10 µM TNP-ATP Fobs. Number
above bar is the number of observations; *, p < 0.01 compared with MBP_1.1C-WT.
) provides an index to the protein
environment provided by the TNP-ATP binding pocket and generally correlates with binding affinity.
values (Fig.
2C) for MBP_1.1C
C84, MBP_1.1C
C160, and MBP_1.1C
C170 were calculated from the protein titration of 5 µM TNP-ATP according to Equation 3. As
expected from the comparison of 10 µM TNP-ATP
fluorescence values shown in Fig. 1B,
was significantly
increased for all three constructs compared with MBP_1.1C-WT (Fig.
2C). The
values for MBP_1.1C
C84, MBP_1.1C
C160, and
MBP_1.1C
C170 were 19.3 ± 0.8, 18.7 ± 0.6, and 19.2 ± 0.2, respectively. The value of
used in Equation 1 for the other
constructs was that of the MBP_1.1C-WT construct (7.7) because
Fobs values were similar (Fig. 1B).
The data in Fig. 1A were well fit by Equation 1
(r2 > 0.99; p < 0.001).

View larger version (13K):
[in a new window]
Fig. 2.
The summary of dissociation constant
(Kd, µM,
(A)), stoichiometry (No
(B)), and enhancement factor
(
; (C)) for TNP-ATP binding
to the MBP fusion proteins containing full-length (WT)
or truncation constructs with deletion of the terminal 84 (
C84), 160 (
C160), and 170 (
C170) amino acid residues.
Kd and No were calculated using Equation 1, using
values derived according to Equation 3 from the protein
titration of 5 µM TNP-ATP. *, p < 0.01 compared with MBP_1.1C-WT or MBP_1.1C
C84.
C84 and reduced in MBP_1.1C
C160 and MBP_1.1C
C170
compared with MBP_1.1C-WT (Fig. 2A): MBP_1.1C-WT = 2.51 ± 0.40; MBP_1.1C
C84 = 3.58 ± 0.23; MBP_1.1C
C160 = 1.18 ± 0.08; MBP_1.1C
C170 = 1.27 ± 0.06. The binding stoichiometry (No; TNP-ATP per protein)
was reduced from 0.78 ± 0.07 in MBP_1.1C-WT to ~0.5 in the
three truncations (Fig. 2B): MBP_1.1C
C84 = 0.49 ± 0.02; MBP_1.1C
C160 = 0.42 ± 0.02; MBP_1.1C
C170 = 0.50 ± 0.02. When taken together, the data in
Figs. 1 and 2 demonstrate that as few as 39 amino acid residues in the
proximal COOH terminus of Kir1.1 (MBP_1.1
C170) are sufficient to
bind TNP-ATP.
N10, MBP_1.1C
N25, MBP_1.1
N50, and
MBP_1.1C
N124) that lack the first 10, 25, 50, and 124 amino acids of
the COOH terminus, respectively, gave no significant TNP-ATP
fluorescence increases (Fig. 3, A and B). The
MBP_1.1
N124 construct consists of the 84 amino acid residues deleted
in the MBP_1.1
C84 construct shown in Fig. 1A. Thus,
deletion of as few as 10 amino acid residues from the
NH2-teminal end of the COOH terminus eliminated TNP-ATP
binding.

View larger version (28K):
[in a new window]
Fig. 3.
The effects of graded truncations of the
proximal region of the COOH terminus of Kir1.1 on
concentration-dependent increases in TNP-ATP
Fobs. MBP fusion protein constructs
with truncations of 10 (MBP_1.1C
N10), 25 (MBP_1.1C
N25), 39 (MBP_1.1C
N39), 50 (MBP_1.1C
N50), 124 (MBP_1.1C
N124) amino acid residues from the
initial COOH terminus of Kir1.1 were produced in bacteria, purified,
and 5-µM concentrations were exposed to varying
concentrations of TNP-ATP. A, TNP-ATP
Fobs was monitored with increasing TNP-ATP
concentrations. The dashed line (FB)
represents free TNP-ATP fluorescence in buffer without protein for
comparison. Fobs increased only minimally over
that for buffer for any of the truncations, indicating little-to-no
significant binding of TNP-ATP to these constructs. B,
TNP-ATP binds to the initial 124 (MBP_1.1C
C84)
but not to the last 84 (MBP_1.1C
N124) amino
acid residues. C, concentration-dependent
TNP-ATP Fobs with deletion of the initial 5 (MBP_1.1C
C160(
N5)) or 10 (MBP_1.1C
C160(
N10)) amino acid
residues in the MBP_1.1C
C160 construct containing the initial 49 amino acids of the Kir1.1 COOH terminus. Fobs
was markedly reduced for either the
N5 or
N10 deletion construct
compared with MBP_1.1C
C160, indicating near abolishment of TNP-ATP
binding. D, TNP-ATP binds to the initial 39 (MBP_1.1C
C170) but not to the last 170 (MBP_1.1C
N39) amino acid residues. The solid and
dashed lines were fit according to Equation 1.
C160 construct that binds TNP-ATP with high affinity (Figs. 1A and
2A). The concentration-dependent TNP-ATP
fluorescence increases were virtually abolished with deletion of the
first 5 or 10 amino acids in MBP_1.1C
C160, MBP_1.1C
C160(
N5), or MBP_1.1C
C160(
N10), respectively (Fig. 3C). Thus,
the initial 5-10 amino acid residues of the COOH terminus of Kir1.1
are crucial for TNP-ATP binding in the entire COOH terminus as well as
the 49-amino acid binding segment in MBP_1.1
C160.
C170), we assessed TNP-ATP fluorescence increases
with MBP_1.1C
C170 compared with MBP_1.1C
N39 (Fig. 3D).
The latter construct represents the 170-amino acid segment of the COOH
terminus following the initial 39 residues. As shown in Fig.
3D, TNP-ATP fluorescence increased significantly in a
concentration-dependent manner with MBP_1.1C
C170 but not
with MBP_1.1C
N39. Thus, the initial 39 amino acid residues of the
Kir1.1 COOH terminus are sufficient to bind TNP-ATP with high affinity
and contain the only TNP-ATP binding site in the Kir1.1 COOH terminus.
derived from Equation 3 was used to calculate the
protein-bound and free TNP-ATP concentrations according to Equation 4
as described in Ref. 19. Plots of these data for MBP_1.1
C160 and
MBP_1.1
C170 are shown in Fig. 4,
A and C, respectively. The data were generally
well fit (r2 = 0.97 (Fig. 4A) and
r2 = 0.95 (Fig. 4B);
p < 0.01) by Equation 5 for a single binding-site model, although some points did deviate slightly from the curve. The
reason for the slight deviations is not clear, although this may
involve some cooperativity associated with protein-protein interactions
in the multimeric forms of these proteins shown previously (1).
Kd values were similar to those determined from the
Fobs data in Fig. 1, and
Bmax gave an N0 (1.9 µM TNP-ATP/5 µM protein) of 0.38 mol of
TNP-ATP/mol protein for MBP_1.1C
C160 and (2.4 µM
TNP-ATP/5 µM protein) of 0.48 mol of TNP-ATP/mol protein for MBP_1.1C
C170. Scatchard plots for MBP_1.1
C160 and
MBP_1.1
C170 are shown in Fig. 4, B and D,
respectively. The Scatchard data were well fit by a linear
non-competitive binding equation (19) as described by Moczydlowski and
Fortes (26) and yielded kinetic parameters similar to those calculated
from the bound versus free curves.

View larger version (22K):
[in a new window]
Fig. 4.
Kinetics of TNP-ATP binding to
MBP_1.1C
C160 and
MBP_1.1C
C170. A and
C, 5-µM protein concentrations were exposed to
varying concentrations of TNP-ATP, and bound and free concentrations of
TNP-ATP were calculated by Equation 4 using the enhancement factors
calculated from Equation 3. The curves were fit according to Equation 5. Maximal TNP-ATP bound (Bmax) values are
shown. B and D, Scatchard plots of TNP-ATP
binding to MBP_1.1
C160 and MBP_1.1
C170. The Scatchard data were
well fit by a linear non-competitive binding equation (19) as described
by Moczydlowski and Fortes (26). The TNP-ATP/protein stoichiometries N
(nmol/mg) and No (Equation 1; mol/mol) and the
Kd (mM) derived from the Scatchard
analyses are shown.
C170. We focused on
four arginine residues, Arg188, Arg203,
Arg212, and Arg217, in Kir1.1 (ROMK1) that are
conserved in Kir6.x COOH termini (Fig. 5)
and have been shown to alter Kir6.2 channel gating by ATP or
PIP2. The effects of mutation of these residues in
MBP_1.1C
C170 on the concentration dependence of TNP-ATP
Fobs are shown in Fig. 6. Mutation of Arg188 to
either a neutral residue, MBP_1.1C
C170(R188A/Q), or to a negatively
charged residue, MBP_1.1C
C170(R188E), resulted in a similar loss of
TNP-ATP-dependent increases in Fobs
(Fig. 6A). Thus, for the other conserved arginine residues
we assessed only the Arg to Ala mutations. TNP-ATP binding was markedly
reduced in the MBP_1.1C
C170(R203A) and MBP_1.1C
C170(R217A) mutant
constructs (Fig. 6, B and D, respectively). In
contrast, mutation of Arg212, MBP_1.1C
C170(R212A), had
no significant effect on the concentration-dependence of TNP-ATP
increases in Fobs compared with MBP_1.1C
C170
(Fig. 6C). The
for MBP_1.1C
C170(R212A) was
significantly higher, whereas the Kd was
significantly lower than for MBP_1.1C
C170: (
) 30.2 ± 0.7 versus 19.2 ± 0.2 (p < 0.01);
(Kd) 0.60 ± 0.09 versus 1.27 ± 0.06.

View larger version (22K):
[in a new window]
Fig. 5.
A, summary of arginine mutations in the
first 39-amino acid residue segment, MBP_1.1C
C170, of Kir1.1
(ROMK1). The mutated arginine residues are indicated by *
with the ROMK1 residue number indicated. The numbers in
parentheses are the corresponding conserved residues in rat
Kir6.2. B, alignment of the initial COOH-terminal segments
of KATP channels. Identical/conserved residues are
shaded. Single letter amino acid codes are used.

View larger version (29K):
[in a new window]
Fig. 6.
TNP-ATP binding to the MBP fusion proteins
with mutations of single conserved arginine residues in
MBP_1.1C
C170. The 39-amino acid region of
MBP_1.1C
C170 with the specific arginine mutation is shown at the
top of each panel. Concentration-dependent
increases in TNP-ATP Fobs are plotted for each
construct with lines fit using Equation 1. The wild-type
(WT) MBP_1.1C
C170 is shown for comparison (clear
squares, dashed line). The low basal fluorescence of
free TNP-ATP in buffer is also shown for comparison (clear
diamonds). The effects of denaturing proteins with 4 M
urea (clear circles, B, and solid
triangles, C and D) are shown in
panels B-D. Mutations of arginine 188 to alanine
(MBP_1.1C
C170(R188A)), arginine 203 to alanine
(MBP_1.1C
C170(R203A)), and arginine 217 to
alanine (MBP_1.1C
C170(R188A)) significantly
reduced TNP-ATP fluorescence increases due to binding. Mutation of
arginine 212 to alanine (MBP_1.1C
C170(R212A))
had no significant effect on TNP-ATP fluorescence increases,
i.e. TNP-ATP binding.
C170. Following binding of 10 µM TNP-ATP, PIP2 was added in increasing
concentrations (Fig. 7A, right panel).
PIP2 reduced 10 µM TNP-ATP
Fobs in MBP_1.1C
C170 in a
concentration-dependent manner with an EC50 of
10.9 ± 0.2 µM. Because TNP-ATP binding was
unaltered in the MBP_1.1
C170(R212A) mutant construct (Fig.
6C) and mutation of a similar arginine residue to the Kir6.2
COOH terminus reduced PIP2 gating sensitivity (14), we
assessed the ability of PIP2 to compete TNP-ATP binding in
MBP_
C170(R212A). Using a similar protocol to that shown
in Fig. 7A, Fig. 7B shows that PIP2
reduced TNP-ATP binding to MBP_1.1
C170(R212A) with an
EC50 of 5.7 ± 0.7 µM (p < 0.001 compared with MBP_1.1
C170). Thus, the R212A mutation
enhanced, rather than diminished, the ability of PIP2 to
compete TNP-ATP binding to MBP_1.1C
C170.

View larger version (21K):
[in a new window]
Fig. 7.
PIP2 reduces TNP-ATP binding to
MBP fusion proteins containing the first 39 amino acid residues of
Kir1.1 COOH terminus
(MBP_1.1C
C170)
(A) or MBP_1.1C
C170
with arginine 212 mutated to alanine
(MBP_1.1C
C170(R212A)
(B). A and B, (left
panels) concentration-dependent increases in TNP-ATP
fluorescence (solid squares). Solid lines fit
using Equation 1. A and B, (right
panels) PIP2 decreases TNP-ATP fluorescence in a
dose-dependent manner to the levels seen with buffer alone
(open squares). The solid line was fit to a
downhill dose-dependent model (GraphPad Prism v. 3.02).
EC50 values for PIP2 competition of TNP-ATP
binding are shown in each panel.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
C170 bound TNP-ATP with higher affinity
than the entire COOH terminus (Figs. 1 and 2, MBP_1.1C-WT)
or any of the other truncation constructs (Figs. 1-4). In addition,
TNP-ATP binding to the construct with a 10-residue greater truncation
(MBP_1.1C
C180) was dramatically reduced compared with
MBP_1.1C
C170 (Fig. 1). Moreover, MBP_1.1
C170 exhibited a
significantly higher
(Fig. 2C) than for MBP_1.1C-WT,
consistent with an improved protein environment for TNP-ATP binding.
Second, the 170-amino acid segment of the COOH terminus beyond the
initial 39 amino acid residues (MBP_1.1C
N39) did not exhibit
significant TNP-ATP binding (Fig. 3D), demonstrating that
nucleotide binding is limited to the first 39 amino acids of the COOH
terminus. Third, truncations of as few as 5 amino acids from the
NH2-terminal end of the COOH terminus (Fig. 3C)
virtually abolished TNP-ATP binding. Fourth, mutation of any one of
three individual residues (Fig. 6, Arg188,
Arg203, or Arg217) within
the 39-amino acid MBP_1.1C
C170 construct abolished TNP-ATP binding,
indicating that they are directly involved in the formation of the
TNP-ATP binding structure of Kir1.1. The observation that R212A did not
alter TNP-ATP binding (Fig. 6C) indicates that the effects
of R188A (Fig. 6A), R203A (Fig. 6B), and R217A
(Fig. 6D) on TNP-ATP binding are unlikely to be nonspecific.
32P]ATP (30), consistent with the
role of the initial region of the Kir6.2 COOH terminus, and by analogy
the Kir1.1 COOH terminus, in ATP/PIP2 effects.
C170
(Fig. 2B) was reduced compared with WT, the stoichiometry of
0.5 is still consistent with one binding site per protein molecule. The
reduced stoichiometry was also observed in MBP_1.1C
C84 and
MBP_1.1C
C160, suggesting that amino acids in the distal COOH
terminus may be involved in the stabilization of the proximal
39-residue adenine nucleotide binding pocket.
![]()
FOOTNOTES
Both authors contributed equally to this work.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Vanoye, C. G.,
MacGregor, G. G.,
Dong, K.,
Tang, L.,
Buschmann, A. E.,
Hall, A. E., Lu, M.,
Giebisch, G.,
and Hebert, S. C.
(2002)
J. Biol. Chem.
277,
23260-23270 2.
MacGregor, G. G.,
Dong, K.,
Vanoye, C. G.,
Tang, L.,
Giebisch, G.,
and Hebert, S. C.
(2002)
Proc. Natl. Acad. Sci., U. S. A.
99,
2726-2731 3.
Ashcroft, S. J. H.,
and Ashcroft, F. M.
(1990)
Cell. Signal.
2,
197-214[CrossRef][Medline]
[Order article via Infotrieve]
4.
Ashcroft, S. J.
(2000)
J. Membr. Biol.
176,
187-206[CrossRef][Medline]
[Order article via Infotrieve]
5.
Edwards, G.,
and Weston, A. H.
(1993)
Annu. Rev. Pharmacol. Toxicol.
33,
597-637[CrossRef][Medline]
[Order article via Infotrieve]
6.
Baukrowitz, T.,
and Fakler, B.
(2000)
Eur. J. Biochem.
267,
5842-5848[Medline]
[Order article via Infotrieve]
7.
Yokoshiki, H.,
Sunagawa, M.,
Seki, T.,
and Sperelakis, N.
(1998)
Am. J. Physiol. (Cell Physiol.)
274,
C25-C37 8.
Aguilar-Bryan, L.,
Clement, J. P.,
Gonzalez, G.,
Kunjilwar, K.,
Babenko, A.,
and Bryan, J.
(1998)
Physiol. Rev.
78,
227-245 9.
Ruknudin, A.,
Schulze, D. H.,
Sullivan, S. K.,
Lederer, W. J.,
and Welling, P. A.
(1998)
J. Biol. Chem.
273,
14165-14171 10.
Tanemoto, M.,
Vanoye, C. G.,
Dong, K.,
Welch, R.,
Abe, T.,
Hebert, S. C.,
and Xu, J. Z.
(2000)
Am. J. Physiol. Renal Physiol.
278,
F659-F666 11.
Wang, W.,
Hebert, S. C.,
and Giebisch, G.
(1997)
Ann. Rev. Physiol.
59,
413-436[CrossRef][Medline]
[Order article via Infotrieve]
12.
Huang, C.-L.,
Feng, S.,
and Hilgemann, D. W.
(1998)
Nature
391,
803-806[CrossRef][Medline]
[Order article via Infotrieve]
13.
Shyng, S. L.,
and Nichols, C. G.
(1998)
Science
282,
1138-1141 14.
Shyng, S. L.,
Cukras, C. A.,
Harwood, J.,
and Nichols, C. G.
(2000)
J. Gen. Physiol.
116,
599-608 15.
Fan, Z.,
and Makielski, J. C.
(1997)
J. Biol. Chem.
272,
5388-5395 16.
Baukrowitz, T.,
Schulte, U.,
Oliver, D.,
Herlitze, S.,
Krauter, T.,
Tucker, S. J.,
Ruppersberg, J. P.,
and Fakler, B.
(1998)
Science
282,
1141-1144 17.
Hilgemann, D. W.,
and Ball, R.
(1996)
Science
273,
956-959[Abstract]
18.
Fan, Z.,
and Makielski, J. C.
(1999)
J. Gen. Physiol.
114,
251-269 19.
Vanoye, C. G.,
MacGregor, G. G.,
Dong, K.,
Tang, L.,
Buschmann, A. E.,
Hall, A. E., Lu, M.,
Giebisch, G.,
and Hebert, S. C.
(2002)
J. Biol. Chem.
272,
23260-23270
20.
Ho, K.,
Nichols, C. G.,
Lederer, W. J.,
Lytton, J.,
Vassilev, P. M.,
Kanazirska, M. V.,
and Hebert, S. C.
(1993)
Nature
362,
31-38[CrossRef][Medline]
[Order article via Infotrieve]
21.
Karolyil, L.,
Konrad, M.,
Kockerling, A.,
Ziegler, A.,
Zimmermann, D. K.,
Roth, B.,
Wieg, C.,
Grzeschik, K.-H.,
Koch, M. C.,
Seyberth, H. W.,
Vargus, R.,
Forestier, L.,
Jean, G.,
Deschaux, M.,
Rizzoni, G. F.,
Niaudet, P.,
Antignac, C.,
Feldman, D.,
Lorridon, F.,
Cougoureux, E.,
Laroze, F.,
Alessandri, J.-L.,
David, L.,
Saunier, P.,
Deschenes, G.,
Hildebrandt, F.,
Vollmer, M.,
Proesmans, W.,
Brandis, M.,
van den Heuvell, L. P. W. J.,
Lemmink, H. H.,
Nillesen, W.,
Monnens, L. A. H.,
Knoers, N. V. A. M.,
Guay-Woodford, L. M.,
Wright, C. J.,
Madrigal, G.,
and Hebert, S. C.
(1997)
Hum. Mol. Genet.
6,
17-26[Medline]
[Order article via Infotrieve]
22.
Simon, D. B.,
Karet, F. E.,
Rodriguez-Soriano, J.,
Hamdan, J. H.,
DiPietro, A.,
Trachtman, H.,
Sanjad, S. A.,
and Lifton, R. P.
(1996)
Nat. Genet.
14,
152-156[CrossRef][Medline]
[Order article via Infotrieve]
23.
Lu, M.,
Wang, T.,
Yan, Q.,
Yang, X.,
Dong, K.,
Knepper, M. A.,
Wang, W.,
Giebisch, G.,
Shull, G. E.,
and Hebert, S. C.
(2002)
J. Biol. Chem.
277,
37881-37887 24.
Wang, C.,
Castro, A. F.,
Wilkes, D. M.,
and Altenberg, G. A.
(1999)
Biochem. J.
338,
77-81[Medline]
[Order article via Infotrieve]
25.
Faller, L. D.
(1990)
Biochemistry
29,
3179-3186[CrossRef][Medline]
[Order article via Infotrieve]
26.
Moczydlowski, E. G.,
and Fortes, P. A.
(1981)
J. Biol. Chem.
256,
2346-2356 27.
Trapp, S.,
Proks, P.,
Tucker, S. J.,
and Ashcroft, F. M.
(1998)
J. Gen. Physiol.
112,
333-349 28.
Tucker, S. J.,
Gribble, F. M.,
Proks, P.,
Trapp, S.,
Ryder, T. J.,
Haug, T.,
Reimann, F.,
and Ashcroft, F. M.
(1998)
EMBO J.
17,
3290-3296[CrossRef][Medline]
[Order article via Infotrieve]
29.
Drain, P., Li, L.,
and Wang, J.
(1998)
Proc. Natl. Acad. Sci., U. S. A.
95,
13953-13958 30.
Tanabe, T.,
Tucker, S. J.,
Matsuo, M.,
Proks, P.,
Ashcroft, F. M.,
Seino, S.,
Amachi, T.,
and Ueda, K.
(1999)
J. Biol. Chem.
274,
3931-3933
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. C. Hernandez, O. Zaika, and M. S. Shapiro A Carboxy-terminal Inter-Helix Linker As the Site of Phosphatidylinositol 4,5-Bisphosphate Action on Kv7 (M-type) K+ Channels J. Gen. Physiol., August 25, 2008; 132(3): 361 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pochynyuk, Q. Tong, J. Medina, A. Vandewalle, A. Staruschenko, V. Bugaj, and J. D. Stockand Molecular Determinants of PI(4,5)P2 and PI(3,4,5)P3 Regulation of the Epithelial Na+ Channel J. Gen. Physiol., September 24, 2007; 130(4): 399 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pochynyuk, Q. Tong, A. Staruschenko, and J. D. Stockand Binding and direct activation of the epithelial Na+ channel (ENaC) by phosphatidylinositides J. Physiol., April 15, 2007; 580(2): 365 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Brady, E. D. Rich, J. R. Martens, J. W. Karpen, M. D. Varnum, and R. L. Brown Interplay between PIP3 and calmodulin regulation of olfactory cyclic nucleotide-gated channels PNAS, October 17, 2006; 103(42): 15635 - 15640. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pochynyuk, Q. Tong, A. Staruschenko, H.-P. Ma, and J. D. Stockand Regulation of the epithelial Na+ channel (ENaC) by phosphatidylinositides Am J Physiol Renal Physiol, May 1, 2006; 290(5): F949 - F957. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pochynyuk, A. Staruschenko, Q. Tong, J. Medina, and J. D. Stockand Identification of a Functional Phosphatidylinositol 3,4,5-Trisphosphate Binding Site in the Epithelial Na+ Channel J. Biol. Chem., November 11, 2005; 280(45): 37565 - 37571. [Abstract] [Full Text] [PDF] |
||||